AIP
SPRB

Ameritas Investment Partners’s Spruce Biosciences SPRB Stock Holding History

Ameritas Investment Partners’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
+247
New +$13.8K ﹤0.01% 2934
2022
Q2 		– Sell
-8
Closed -$1K – 3268
2022
Q1 		$1K Hold
8
– – ﹤0.01% 3072
2021
Q4 		$3K Hold
8
– – ﹤0.01% 3085
2021
Q3 		$4K Hold
8
– – ﹤0.01% 3056
2021
Q2 		$7K Hold
8
– – ﹤0.01% 2975
2021
Q1 		$10K Hold
8
– – ﹤0.01% 2874
2020
Q4 		$14K Buy
+8
New +$13.3K ﹤0.01% 2660

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Ameritas Investment Partners's SPRB Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 247 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #2934 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in SPRB as recently as Q1 2022.

Ameritas Investment Partners first reported a position in SPRB in Q4 2020 and has held it in 7 quarters since. The position peaked at $14K in Q4 2020. 28 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Ameritas Investment Partners held 247 shares of Spruce Biosciences worth $13.3K as of Q2 2026.
  • Spruce Biosciences was a new Ameritas Investment Partners position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2934 holding.
  • Ameritas Investment Partners first reported a position in Spruce Biosciences in Q4 2020 and has held it in 7 quarters since.
  • Ameritas Investment Partners's Spruce Biosciences position peaked at $14K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.